Shop
eStoreRx™
Online Supplement Dispensary
eStoreRx™ is an easy direct-to-patient ordering & fulfilment program for lifelong wellness.
For over 40 years, Biotics Research Corporation has revolutionized the nutritional supplement industry by utilizing “The Best of Science and Nature”. Combining nature’s principles with scientific ingenuity, our products magnify the nutritional
eStoreRx™ is an easy direct-to-patient ordering & fulfilment program for lifelong wellness.
Biotics Research is proud to expand our commitment to education with the Wellness Unfiltered Pro Podcast. Each episode delves into key health topics and the clinical applications of our premier products. Through candid, insightful conversations, our team offers practical guidance to keep you informed and empowered as a healthcare professional.
November 21 2024
The protective association between dietary flavonoid intake and the risk of dementia has been the focus of yet another study; this one being published...
The Lancet has just published the results of the first randomized and controlled trial evaluating the effect of hearing aids on cognitive decline and dementia when given to older adults with hearing loss. A substantial body of evidence suggests that hearing loss, which is quite common among older adults, is associated with a greater risk for both cognitive decline and dementia. Additionally, a systematic review of observational studies published in JAMA Neurology earlier this year indicates that the use of hearing restoration devices mitigates some of this risk. However, until now no interventional trials have yet been conducted.
Titled the ACHIEVE (Aging and Cognitive Health Evaluation in Elders) study, 2 separate cohorts of adults aged 70-84 were randomized (but unblinded) to receive either audiologist-supplied hearing aids or an evidence-based program taught by a certified health educator. They were evaluated with a variety of cognition-based exams annually over a 3-year period.
Although overall no effect of hearing aids was observed, the results were quite encouraging. When analysis was restricted to one of the cohorts, participants in ARIC (Atherosclerosis Risk in Communities), had a 48% reduction in cognitive decline over the 3-year period when given hearing aids. This cohort was considered to be at higher risk for decline compared to the second cohort (which was younger, had higher education levels, fewer cardiovascular risk factors, etc.). The rate of decline in ARIC was greater, perhaps allowing for an effect to be observed within only a 3-year period. This study clearly shows benefits for those at high risk of decline, and it remains possible that a benefit exists even for those not considered high-risk, but 3 years may not be enough time to detect it.
Submit this form and you'll receive our latest news and updates.
Results of a randomized controlled trial performed to evaluate the effectiveness of a prebiotic supplement on both muscl...
Learn moreResults of a cross-sectional study were recently published in the Journal of Translational Medicine, detailing the assoc...
Learn moreThe results of a 10-year longitudinal study were recently published in The Lancet Healthy Longevity, detailing the assoc...
Learn more
*These statements have not been evaluated by the Food and Drug Administration. This product has not intended to diagnose, treat, cure, or prevent any disease.
© 2023 Biotics Research Corporation - All Rights Reserved
Submit your comment